Stempoint Capital »

Pasithea Therapeutics Corp shares owned by Stempoint Capital

Quarter-by-quarter ownership of Pasithea Therapeutics Corp (KTTA) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Pasithea Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Pasithea Therapeutics Corp held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pasithea Therapeutics Corp by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $458k 355k 1.29

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Scholar Rock Hldg Corp (SRRK)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Syndax Pharmaceuticals (SNDX)
Structure Therapeutics Sponsored Ads (GPCR)
Arcellx Common Stock (ACLX)
Roivant Sciences SHS (ROIV)
Terns Pharmaceuticals (TERN)
Twist Bioscience Corp (TWST)
Immunovant (IMVT)
Dyne Therapeutics (DYN)
Xenon Pharmaceuticals (XENE)
Surrozen Com New (SRZN)
Celcuity (CELC)
Mineralys Therapeutics (MLYS)

View all positions for Stempoint Capital

Top funds holding Pasithea Therapeutics Corp

Vivo Capital
Cable Car Capital
Longwood Capital Partners
Stempoint Capital
AdvisorShares Investments
Stonepine Capital Management
Vanguard Group
Citadel Advisors
Jane Street
Geode Capital Management
Two Sigma Investments
Northern Trust
XTX Topco
UBS Group
Hurley Capital

View all funds holding Pasithea Therapeutics Corp